The Fuss Over Who Should Declare Public Health Emergencies in Africa 20/06/2022 Paul Adepoju Africa CDC wants to be able to declare public health emergencies of continental security but the WHO warns this could be a risky move that could isolate African countries and create confusion regarding response. The World Health Organization’s African Regional Office (WHO AFRO) has found itself explaining its disapproval of the Africa CDC’s quest for […] Continue reading -> WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> Monkeypox: Africa CDC Demands Equal Treatment in Global Allocation of Limited Vaccine Doses 16/06/2022 Paul Adepoju Rich countries are rushing to get doses – but African countries say they should get the vaccines first for a disease endemic to the continent. A plan by the World Health Organization (WHO) to create a vaccine sharing mechanism that will attempt to provide equitable access to vaccines effective against monkeypox disease will only be […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> WTO Opens with Note of ‘Cautious Optimism’ on Prospects for Agreement over Fisheries Subsidies and COVID Vaccine IP Waiver 12/06/2022 Elaine Ruth Fletcher The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans […] Continue reading -> Moderna Doses First Participants in Phase 3 Study of mRNA Flu Vaccine 07/06/2022 Maayan Hoffman Moderna announced Tuesday that the first participants have been vaccinated in a Phase 3 study of its influenza (flu) vaccine, which is based on mRNA technology used in its COVID-19 vaccine. The vaccine, mRNA-1010, encodes for hemagglutinin (HA) glycoproteins of the four influenza strains recommended by the World Health Organization (WHO) for the prevention of […] Continue reading -> Pfizer’s Antiviral Drug May Have Potential as Long COVID Treatment 06/06/2022 Maayan Hoffman Scientists and doctors are beginning to eye Paxlovid, the antiviral medicine developed by Pfizer to protect vulnerable people from severe disease, as a potential treatment for lingering COVID-19 symptoms after single patients report that the medicine has helped to reduce their symptoms. Long COVID affects as many as one in five people infected by the […] Continue reading -> Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press […] Continue reading -> Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> Monkeypox: Africa CDC Demands Equal Treatment in Global Allocation of Limited Vaccine Doses 16/06/2022 Paul Adepoju Rich countries are rushing to get doses – but African countries say they should get the vaccines first for a disease endemic to the continent. A plan by the World Health Organization (WHO) to create a vaccine sharing mechanism that will attempt to provide equitable access to vaccines effective against monkeypox disease will only be […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> WTO Opens with Note of ‘Cautious Optimism’ on Prospects for Agreement over Fisheries Subsidies and COVID Vaccine IP Waiver 12/06/2022 Elaine Ruth Fletcher The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans […] Continue reading -> Moderna Doses First Participants in Phase 3 Study of mRNA Flu Vaccine 07/06/2022 Maayan Hoffman Moderna announced Tuesday that the first participants have been vaccinated in a Phase 3 study of its influenza (flu) vaccine, which is based on mRNA technology used in its COVID-19 vaccine. The vaccine, mRNA-1010, encodes for hemagglutinin (HA) glycoproteins of the four influenza strains recommended by the World Health Organization (WHO) for the prevention of […] Continue reading -> Pfizer’s Antiviral Drug May Have Potential as Long COVID Treatment 06/06/2022 Maayan Hoffman Scientists and doctors are beginning to eye Paxlovid, the antiviral medicine developed by Pfizer to protect vulnerable people from severe disease, as a potential treatment for lingering COVID-19 symptoms after single patients report that the medicine has helped to reduce their symptoms. Long COVID affects as many as one in five people infected by the […] Continue reading -> Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press […] Continue reading -> Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Monkeypox: Africa CDC Demands Equal Treatment in Global Allocation of Limited Vaccine Doses 16/06/2022 Paul Adepoju Rich countries are rushing to get doses – but African countries say they should get the vaccines first for a disease endemic to the continent. A plan by the World Health Organization (WHO) to create a vaccine sharing mechanism that will attempt to provide equitable access to vaccines effective against monkeypox disease will only be […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> WTO Opens with Note of ‘Cautious Optimism’ on Prospects for Agreement over Fisheries Subsidies and COVID Vaccine IP Waiver 12/06/2022 Elaine Ruth Fletcher The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans […] Continue reading -> Moderna Doses First Participants in Phase 3 Study of mRNA Flu Vaccine 07/06/2022 Maayan Hoffman Moderna announced Tuesday that the first participants have been vaccinated in a Phase 3 study of its influenza (flu) vaccine, which is based on mRNA technology used in its COVID-19 vaccine. The vaccine, mRNA-1010, encodes for hemagglutinin (HA) glycoproteins of the four influenza strains recommended by the World Health Organization (WHO) for the prevention of […] Continue reading -> Pfizer’s Antiviral Drug May Have Potential as Long COVID Treatment 06/06/2022 Maayan Hoffman Scientists and doctors are beginning to eye Paxlovid, the antiviral medicine developed by Pfizer to protect vulnerable people from severe disease, as a potential treatment for lingering COVID-19 symptoms after single patients report that the medicine has helped to reduce their symptoms. Long COVID affects as many as one in five people infected by the […] Continue reading -> Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press […] Continue reading -> Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> WTO Opens with Note of ‘Cautious Optimism’ on Prospects for Agreement over Fisheries Subsidies and COVID Vaccine IP Waiver 12/06/2022 Elaine Ruth Fletcher The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans […] Continue reading -> Moderna Doses First Participants in Phase 3 Study of mRNA Flu Vaccine 07/06/2022 Maayan Hoffman Moderna announced Tuesday that the first participants have been vaccinated in a Phase 3 study of its influenza (flu) vaccine, which is based on mRNA technology used in its COVID-19 vaccine. The vaccine, mRNA-1010, encodes for hemagglutinin (HA) glycoproteins of the four influenza strains recommended by the World Health Organization (WHO) for the prevention of […] Continue reading -> Pfizer’s Antiviral Drug May Have Potential as Long COVID Treatment 06/06/2022 Maayan Hoffman Scientists and doctors are beginning to eye Paxlovid, the antiviral medicine developed by Pfizer to protect vulnerable people from severe disease, as a potential treatment for lingering COVID-19 symptoms after single patients report that the medicine has helped to reduce their symptoms. Long COVID affects as many as one in five people infected by the […] Continue reading -> Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press […] Continue reading -> Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> WTO Opens with Note of ‘Cautious Optimism’ on Prospects for Agreement over Fisheries Subsidies and COVID Vaccine IP Waiver 12/06/2022 Elaine Ruth Fletcher The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans […] Continue reading -> Moderna Doses First Participants in Phase 3 Study of mRNA Flu Vaccine 07/06/2022 Maayan Hoffman Moderna announced Tuesday that the first participants have been vaccinated in a Phase 3 study of its influenza (flu) vaccine, which is based on mRNA technology used in its COVID-19 vaccine. The vaccine, mRNA-1010, encodes for hemagglutinin (HA) glycoproteins of the four influenza strains recommended by the World Health Organization (WHO) for the prevention of […] Continue reading -> Pfizer’s Antiviral Drug May Have Potential as Long COVID Treatment 06/06/2022 Maayan Hoffman Scientists and doctors are beginning to eye Paxlovid, the antiviral medicine developed by Pfizer to protect vulnerable people from severe disease, as a potential treatment for lingering COVID-19 symptoms after single patients report that the medicine has helped to reduce their symptoms. Long COVID affects as many as one in five people infected by the […] Continue reading -> Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press […] Continue reading -> Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WTO Opens with Note of ‘Cautious Optimism’ on Prospects for Agreement over Fisheries Subsidies and COVID Vaccine IP Waiver 12/06/2022 Elaine Ruth Fletcher The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans […] Continue reading -> Moderna Doses First Participants in Phase 3 Study of mRNA Flu Vaccine 07/06/2022 Maayan Hoffman Moderna announced Tuesday that the first participants have been vaccinated in a Phase 3 study of its influenza (flu) vaccine, which is based on mRNA technology used in its COVID-19 vaccine. The vaccine, mRNA-1010, encodes for hemagglutinin (HA) glycoproteins of the four influenza strains recommended by the World Health Organization (WHO) for the prevention of […] Continue reading -> Pfizer’s Antiviral Drug May Have Potential as Long COVID Treatment 06/06/2022 Maayan Hoffman Scientists and doctors are beginning to eye Paxlovid, the antiviral medicine developed by Pfizer to protect vulnerable people from severe disease, as a potential treatment for lingering COVID-19 symptoms after single patients report that the medicine has helped to reduce their symptoms. Long COVID affects as many as one in five people infected by the […] Continue reading -> Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press […] Continue reading -> Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna Doses First Participants in Phase 3 Study of mRNA Flu Vaccine 07/06/2022 Maayan Hoffman Moderna announced Tuesday that the first participants have been vaccinated in a Phase 3 study of its influenza (flu) vaccine, which is based on mRNA technology used in its COVID-19 vaccine. The vaccine, mRNA-1010, encodes for hemagglutinin (HA) glycoproteins of the four influenza strains recommended by the World Health Organization (WHO) for the prevention of […] Continue reading -> Pfizer’s Antiviral Drug May Have Potential as Long COVID Treatment 06/06/2022 Maayan Hoffman Scientists and doctors are beginning to eye Paxlovid, the antiviral medicine developed by Pfizer to protect vulnerable people from severe disease, as a potential treatment for lingering COVID-19 symptoms after single patients report that the medicine has helped to reduce their symptoms. Long COVID affects as many as one in five people infected by the […] Continue reading -> Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press […] Continue reading -> Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer’s Antiviral Drug May Have Potential as Long COVID Treatment 06/06/2022 Maayan Hoffman Scientists and doctors are beginning to eye Paxlovid, the antiviral medicine developed by Pfizer to protect vulnerable people from severe disease, as a potential treatment for lingering COVID-19 symptoms after single patients report that the medicine has helped to reduce their symptoms. Long COVID affects as many as one in five people infected by the […] Continue reading -> Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press […] Continue reading -> Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press […] Continue reading -> Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Posts navigation Older postsNewer posts